Using the drug-protein interactome to identify anti-ageing compounds for humans
Using the drug-protein interactome to identify anti-ageing compounds for humans
复制标题
使用药物-蛋白质相互作用组来识别人类抗衰老化合物
DOI:
10.1101/438234
复制
发表时间:
2018
期刊:
影响因子:
--
通讯作者:
Fuentealba Valenzuela M
中科院分区:
文献类型:
--
作者:
Fuentealba Valenzuela M
Advancing age is the dominant risk factor for most of the major killer diseases in developed countries. Hence, ameliorating the effects of ageing may prevent multiple diseases simultaneously. Drugs licensed for human use against specific diseases have proved to be effective in extending lifespan and healthspan in animal models, suggesting that there is scope for drug repurposing in humans. New bioinformatic methods to identify and prioritise potential anti-ageing compounds for humans are therefore of interest. In this study, we first used drug-protein interaction information, to rank 1,147 drugs by their likelihood of targeting ageing-related gene products in humans. Among 19 statistically significant drugs, 6 have already been shown to have pro-longevity properties in animal models (p< 0.001). Using the targets of each drug, we established its association with ageing at multiple levels of biological actions including pathways, functions and protein interactions. Finally, combining all the data, we calculated a comprehensive ranked list of drugs that predicted tanespimycin, an inhibitor of HSP-90, as the top-ranked novel anti-ageing candidate. We experimentally validated the pro-longevity effect of tanespimycin through its HSP-90 target in Caenorhabditis elegans.
登录
查看更多内容
DOI:
10.1093/gerona/glr223
发表时间:
2012-04-01
影响因子:
5.1
作者:
Andersen, Stacy L.;Sebastiani, Paola;Perls, Thomas T.
通讯作者:
Perls, Thomas T.
影响因子:
64.8
作者:
L. Partridge
通讯作者:
L. Partridge
影响因子:
2.6
作者:
Buttiglieri, Stefano;Ruella, Marco;Tarella, Corrado
通讯作者:
Tarella, Corrado
影响因子:
29
作者:
Barzilai N;Crandall JP;Kritchevsky SB;Espeland MA
通讯作者:
Espeland MA
影响因子:
17.1
作者:
Mannick, Joan B.;Morris, Melody;Klickstein, Lloyd B.
通讯作者:
Klickstein, Lloyd B.